Geographic Atrophy Treatment Market Opportunities, Business Forecast To 2029

The global geographic atrophy treatment market size was valued at USD 32.6 billion in 2022 and is poised to grow at a CAGR of 11.2% during the forecast period 2023 to 2029. The primary factors that drive the market are the growing prevalence of Dry Muscular degeneration causes atrophy in the geriatric population, rising healthcare infrastructure, and increasing demand for novel drugs for the efficient treatment options of geographic atrophy.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/geographic-atrophy-treatment-market

Dry Muscular Degeneration is a Major Cause of Geographic Atrophy Treatment Market Growth:
Dry muscular degeneration holds the highest market share due to high incidences across the world. Dry muscular degeneration is a common eye disorder among people over 50 years, it causes blurred eye vision due to the breaking down of the inner layer of the macula, the rapidly increasing geriatric population demands effective treatment options, FDA and Other Drugs regulatory authorities are continuous focusing on clinical trials of the geography atrophy treatment drugs to develop patient-friendly dosage, overall contributing to treatment drive the market growth with significant growth.

Asia Pacific Geographic Atrophy Treatment Market:
Asia Pacific region is expected to grow significantly in the global Geographic Atrophy Treatment Market size over the forecast period. It is attributed to the increasing number of eye disorders and dry muscular degeneration demands for operative treatment options. According to the National Institutes of Health, Geographic atrophy was more prevalent in South Asia (based on studies from India and Nepal, 3.82 per 1000 persons) compared with East Asia (based on studies from China, Korea, Hong Kong, Taiwan, and Japan, and the Singapore Chinese Eye Study, 0.76 per 1000 persons). the high rate of prevalence and increasing well-developed infrastructure it is expected to grow at a significant rate in the forecast years.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the Key Strategies Adopted by Market Players:
The global Geographic Atrophy Treatment Market further reveals that the key players are implementing strategies such as the extension of product collection through research and development activities, product launches, acquisitions, mergers, and strategic alliances to improve their market position and strengthen the market revenue share., In February 2023, The FDA approved pegcetacoplan under the name "Syfovre" as the first treatment for GA by Apellis Pharmaceuticals -an advanced stage of age-related macular degeneration that is also a leading cause of blindness.

The Geographic Atrophy Treatment Market is segmented based on diagnosis, clinical trials end-user, and region.
Based on the diagnosis, the market is segmented into the following:
• Fundus Autofluorescence (FAF)
• Optical Coherence Tomography Angiography (OCT-A)
• Multifocal Electroretinography (mfERG)

Based on the clinical trials, the market is segmented into the following:
• Phase III
• Phase II
• Phase I
• Preclinical

Based on the end user, the market is segmented into the following:
• Hospitals
• Ambulatory Surgical Centres
• Diagnostic Centres
• Others

Based on the region, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=845526

Key players' profiles in the geographic atrophy treatment market report are Allergan, Hemera Biosciences, Roche, Iveric Bio, NGM Biopharmaceuticals, Allegro Ophthalmics, Alkeus Pharmaceuticals, Gensight Biologics, AstraZeneca, Stealth BioTherapeutics, Gyroscope Therapeutics, Apellis Pharmaceuticals, Lineage Cell Therapeutics, and Regenerative Patch Technologies

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.